Apollo Hospitals Enterprise Limited has announced its unaudited financial results for the first quarter of FY27, ending June 30, 2026. The company’s board also approved the appointment of M/s Price Waterhouse Chartered Accountants LLP as its new statutory auditors for a five-year term, commencing from the conclusion of the 46th AGM in 2027. Additionally, strategic business updates including the transfer of an undertaking by Apollo Healthco Limited and the grant of stock options were disclosed.
Apollo Hospitals Reports Q1FY27 Financial Performance
Apollo Hospitals Enterprise Limited released its unaudited standalone financial results for the quarter ended June 30, 2026. The company reported a profit after tax of ₹3,852 million for the quarter. Revenue from operations stood at ₹26,561 million, with total income reaching ₹27,032 million. Total expenses were recorded at ₹22,025 million.
Key Financial Highlights (Standalone)
- Revenue from operations: ₹26,561 million (Q1 FY27)
- Profit after tax: ₹3,852 million (Q1 FY27)
- Earnings per share (Basic): ₹26.79 (Q1 FY27)
- Earnings per share (Diluted): ₹26.78 (Q1 FY27)
Consolidated Financial Performance
The consolidated unaudited financial results for the three months ended June 30, 2026, showed total revenue of ₹70,923 million and profit after tax attributable to owners of the parent at ₹5,807 million. The consolidated total comprehensive income for the period was ₹6,143 million.
Auditor Appointment and Business Updates
In a significant decision, the Board of Directors approved the appointment of M/s Price Waterhouse Chartered Accountants LLP as the Statutory Auditors for a term of five years, beginning after the 46th Annual General Meeting (AGM) in 2027, subject to member approval. They will succeed the current auditors, M/s Deloitte Haskins & Sells LLP. The Board also noted the proposed transfer of an undertaking by Apollo Healthco Limited to its wholly-owned subsidiary, Apollo Consumer Products Limited (ACPL), on a slump sale basis. Furthermore, the grant of additional stock options and RSUs under the Apollo ESOP Plan 2024 was approved for 46,798 equity shares.
Operational Milestones
The company’s press release highlighted a strong Q1 FY27 performance with consolidated revenue growing 21% YoY to ₹7,043 Crore and consolidated EBITDA increasing by 28% YoY to ₹1,092 Crore. Strategic initiatives include the launch of a 180-bed hospital in Sarjapur, Bangalore, and plans to add over 5800 beds in the next five years.
Source: BSE
